Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
Peeling Back The Layers: Exploring Anika Therapeutics Through Analyst Insights
揭開層面：通過分析師見解探索阿尼卡療法
In the latest quarter, 4 analysts provided ratings for Anika Therapeutics (NASDAQ:ANIK), showcasing a mix of bullish and bearish perspectives.
在最近一個季度中，4位分析師爲Anika Therapeutics（納斯達克股票代碼：ANIK）提供了評級，顯示了看漲和看跌的觀點。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表總結了他們最近的評級，展示了過去30天內不斷變化的情緒，並將其與前幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Anika Therapeutics, presenting an average target of $30.0, a high estimate of $37.00, and a low estimate of $22.00. Consistency is reflected as the current average remains at the same level as the previous average price target.
在評估12個月目標股價時，分析師公佈了對Anika Therapeutics的見解，將平均目標股價定爲30.0美元，最高估計爲37.00美元，低估值爲22.00美元。一致性體現在當前的平均水平與之前的平均目標價格保持在同一水平。
Investigating Analyst Ratings: An Elaborate Study
調查分析師評級：一項詳盡的研究
The standing of Anika Therapeutics among financial...
通過對分析師近...
登入免費觀看全文
登入/註冊